Evidence map›Paper›PMID 30736367›Full record

ArticlePharmaceutics2019

Preparation and Characterization of New Liposomes. Bactericidal Activity of Cefepime Encapsulated into Cationic Liposomes.

Maria Luisa Moyá, Manuel López-López, José Antonio Lebrón, Francisco José Ostos, David Pérez, Vanesa Camacho, Irene Beck, Vicente Merino-Bohórquez, Manuel Camean, Nuria Madinabeitia and 1 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Research Status and Prospect of Non-Viral Vectors Based on siRNA: A Review.International journal of molecular sciences · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Nanoencapsulation ofBioImpacts : BI · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Maria Luisa MoyáDepartment of Physical Chemistry, University of Seville, 41012 Seville, Spain. moya@us.es.
Manuel López-LópezDepartament of Chemical Engineering, Physical Chemistry and Material Science. Faculty of Experimental Sciences, University of Huelva, Campus El Carmen, E-21071 Huelva, Spain. manuel.lopez@diq.uhu.es.ORCID 0000-0001-9060-9554
José Antonio LebrónDepartment of Physical Chemistry, University of Seville, 41012 Seville, Spain. lebronjunior@hotmail.com.
Francisco José OstosDepartment of Physical Chemistry, University of Seville, 41012 Seville, Spain. fraostmar@alum.us.es.
David PérezDepartment of Physical Chemistry, University of Seville, 41012 Seville, Spain. david_perezalf@hotmail.com.
Vanesa CamachoDepartment of Physical Chemistry, University of Seville, 41012 Seville, Spain. vane_farma@hotmail.com.
Irene BeckDepartment of Physical Chemistry, University of Seville, 41012 Seville, Spain. irenebeckdiaz93@gmail.com.
Vicente Merino-BohórquezDepartament of Microbiology, Faculty of Biology, University of Sevilla, 41012 Seville, Spain. vicenmb@hotmail.com.
Manuel CameanDepartament of Microbiology, Faculty of Biology, University of Sevilla, 41012 Seville, Spain. manuel.camean.sspa@juntadeandalucia.es.
Nuria MadinabeitiaHospital Pharmacy Area, University Hospital Virgen Macarena, 41009 Seville, Spain. nuria@us.es.
Pilar López-CornejoDepartment of Physical Chemistry, University of Seville, 41012 Seville, Spain. pcornejo@us.es.ORCID 0000-0002-5825-9483
Universidad de Sevilla · ESHospital Universitario Virgen Macarena · ESUniversidad de Huelva · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cefepime is an antibiotic with a broad spectrum of antimicrobial activity. However, this antibiotic has several side effects and a high degradation rate. For this reason, the preparation and characterization of new liposomes that are able to encapsulate this antibiotic seem to be an important research line in the pharmaceutical industry. Anionic and cationic liposomes were prepared and characterized. All cationic structures contained the same cationic surfactant,

Indexed as

bactericidal activitycefepimeencapsulationliposomesurfactant.zeta potential

Identifiers

PMID30736367
PMCPMC6410124
OpenAlexW2914632087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.